Implications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer Drugs
- 1 January 2015
- book chapter
- Published by Elsevier
- Vol. 98, 169-221
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Enhanced apoptotic effects of dihydroartemisinin‐aggregated gelatin and hyaluronan nanoparticles on human lung cancer cellsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2013
- Impact of albumin on drug delivery — New applications on the horizonJournal of Controlled Release, 2012
- Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymersJournal of Controlled Release, 2011
- Drug delivery to solid tumors by elastin-like polypeptidesAdvanced Drug Delivery Reviews, 2010
- Silk-based delivery systems of bioactive moleculesAdvanced Drug Delivery Reviews, 2010
- Injectable intratumoral depot of thermally responsive polypeptide–radionuclide conjugates delays tumor progression in a mouse modelJournal of Controlled Release, 2010
- The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticlesJournal of Biomedical Research, 2010
- Targeting of albumin-embedded paclitaxel nanoparticles to tumorsNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Temperature Triggered Self-Assembly of Polypeptides into Multivalent Spherical MicellesJournal of the American Chemical Society, 2007
- Poly(ethylene glycol)–modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2007